Question · Q4 2025
Christopher Carey asked about Colgate-Palmolive's balance sheet strength and its approach to M&A, inquiring if the recent impairment changes views on target categories, the desire for M&A, and the evolving thought process on assets or categories of interest.
Answer
Stan Sutula, CFO, highlighted the improved balance sheet and cash flow (record $4.2B operating cash flow in 2025), providing flexibility and dry powder. Capital allocation priorities are investing in the business, returning to shareholders (dividends, buybacks), and M&A. He stated they look for opportunities to improve the portfolio, demonstrating discipline, and cited Hill's acquisitions (Red Collar, Prime100) as examples. The impairment is part of running the business, not changing long-term belief in the business. Noel Wallace, Chairman, President, and CEO, added that they are cautious in the uncertain environment but would use the balance sheet for the right opportunities, prioritizing investment in growth.
Ask follow-up questions
Fintool can predict
CL's earnings beat/miss a week before the call


